Baselayer Capital — Full Portfolio
3 tracked investments · listed companies and verified rows first
BlueWhale Bio develops manufacturing technologies for cell-based therapies, focusing on cell activation and expansion in early-stage processing to improve efficiency and reduce costs.
BiotechDeep TechMedical DevicesPhiladelphia, US
Peter Keller(Executive Officer, Director)in
BoardPaul Meister(Director)Elaine Heron(Director)Paula Cannon(Director)Beate Mueller-Tiemann(Director)
Co-investorsAscendo VenturesNovalis LifeSciencesCardanoGhaf Capital Partnersgumi IncPRIMAL CAPITAL+2 more
DashLX provides a platform for real-world product testing that combines behavioral data from wearables and mobile devices with survey responses from actual customers at scale.
ConsumerData & InfrastructureMarketing TechRetail TechSaaS
Adam Stepanovicin
Co-investorsAZ Venture Capital Inc.Accelerator Ventures
Mytaverse offers a browser-based, hardware-agnostic platform that uses AI-powered immersive 3D environments to train and onboard workers at large, distributed enterprises.
AI & Machine LearningEdTechEnterprise SoftwareMiami, US
KENNETH LANDAU(Executive Officer, Director)
BoardDAVID BLUMBERG(Director)inALBERTO PEISACH(Director)JOHN PAUL MILCIUNAS(Director)inJAIME LOPEZ(Director)
Co-investorsBlumberg CapitalCorrelation VenturesAccelerator VenturesBaseLayer VenturesMiami Angels
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.